Potomac, MD, United States of America

Jeannine D Gocayne

USPTO Granted Patents = 19 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Silver Spring, MD (US) (1996 - 2003)
  • Potomac, MD (US) (1998 - 2006)

Company Filing History:


Years Active: 1996-2006

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Jeannine D Gocayne: Innovations in Neuroscience and Therapeutics

Introduction

Jeannine D Gocayne, based in Potomac, MD, is a prolific inventor with a remarkable portfolio that includes 19 patents. Her work primarily focuses on biopharmaceutical innovations that aim to address cognitive and neurological deficiencies, contributing significantly to the advancement of treatments for degenerative nervous system disorders.

Latest Patents

Jeannine's latest patents include groundbreaking developments in human choline acetyltransferase polypeptides and DNA encoding such polypeptides. These inventions outline a procedure for producing the polypeptide through recombinant techniques. Moreover, her patents detail methods for utilizing this polypeptide in treating conditions such as Alzheimer's Disease, ALS, and other cholinergic defects. She also provides insights into antagonists effective for treating Parkinson's Disease and related disorders linked to acetylcholine over-expression. Additionally, her diagnostic methods for detecting mutations in the human Choline Acetyltransferase nucleic acid sequence offer innovative avenues for medical diagnostics. Another significant patent involves human Inositol Monophosphatase H1, outlining polynucleotides, procedures for producing these polypeptides, and therapeutic applications for mental health disorders.

Career Highlights

Throughout her distinguished career, Jeannine has worked with Human Genome Sciences, Inc., a company renowned for its groundbreaking work in genomic medicine. Her contributions have advanced the field of neuroscience and enhanced our understanding of genetic influences on cognitive function and mental health.

Collaborations

Jeannine has collaborated with notable colleagues, including Craig A Rosen and Paul S Meissner. Their collective expertise has fostered innovative research that has the potential to influence future therapeutic developments in treating neurological and psychiatric conditions.

Conclusion

Jeannine D Gocayne's contributions to neuroscience through her patents and collaborative work have established her as a leading figure in her field. Her innovations are poised to make significant impacts on the treatment of cognitive and neurological disorders, thereby enhancing the quality of life for those affected. Her dedication to advancing medical science illustrates the profound influence of inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…